Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency - PubMed (original) (raw)

. 1998 May 29;280(5368):1432-5.

doi: 10.1126/science.280.5368.1432.

A Durandy, D Lammas, J F Emile, S Lamhamedi, F Le Deist, P Drysdale, E Jouanguy, R Döffinger, F Bernaudin, O Jeppsson, J A Gollob, E Meinl, A W Segal, A Fischer, D Kumararatne, J L Casanova

Affiliations

• PMID: 9603732
• DOI: 10.1126/science.280.5368.1432

Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

F Altare et al. Science. 1998.

Abstract

In humans, interferon gamma (IFN-gamma) receptor deficiency leads to a predisposition to mycobacterial infections and impairs the formation of mature granulomas. Interleukin-12 (IL-12) receptor deficiency was found in otherwise healthy individuals with mycobacterial infections. Mature granulomas were seen, surrounded by T cells and centered with epithelioid and multinucleated giant cells, yet reduced IFN-gamma concentrations were found to be secreted by activated natural killer and T cells. Thus, IL-12-dependent IFN-gamma secretion in humans seems essential in the control of mycobacterial infections, despite the formation of mature granulomas due to IL-12-independent IFN-gamma secretion.

PubMed Disclaimer

Similar articles

• Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.
  de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP, Casanova JL, Ottenhoff TH. de Jong R, et al. Science. 1998 May 29;280(5368):1435-8. doi: 10.1126/science.280.5368.1435. Science. 1998. PMID: 9603733
• Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
  Verhagen CE, de Boer T, Smits HH, Verreck FA, Wierenga EA, Kurimoto M, Lammas DA, Kumararatne DS, Sanal O, Kroon FP, van Dissel JT, Sinigaglia F, Ottenhoff TH. Verhagen CE, et al. J Exp Med. 2000 Aug 21;192(4):517-28. doi: 10.1084/jem.192.4.517. J Exp Med. 2000. PMID: 10952721 Free PMC article.
• Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections.
  Gollob JA, Veenstra KG, Jyonouchi H, Kelly AM, Ferrieri P, Panka DJ, Altare F, Fieschi C, Casanova JL, Frank DA, Mier JW. Gollob JA, et al. J Immunol. 2000 Oct 1;165(7):4120-6. doi: 10.4049/jimmunol.165.7.4120. J Immunol. 2000. PMID: 11034424
• [Mendelian predisposition to mycobacterial infections in humans].
  Casanova JL. Casanova JL. J Soc Biol. 2000;194(1):25-8. J Soc Biol. 2000. PMID: 11107546 Review. French.
• Clinical and immunologic features of an atypical intracranial mycobacterium avium complex (MAC) infection compared with those of pulmonary MAC infections.
  Sadek M, Yue FY, Lee EY, Gyenes G, Jones RB, Hoffstein V, Munoz DG, Fong I, Ostrowski M. Sadek M, et al. Clin Vaccine Immunol. 2008 Oct;15(10):1580-9. doi: 10.1128/CVI.00173-08. Epub 2008 Aug 13. Clin Vaccine Immunol. 2008. PMID: 18701648 Free PMC article. Review.

Cited by

• Age-dependent association between pulmonary tuberculosis and common TOX variants in the 8q12-13 linkage region.
  Grant AV, El Baghdadi J, Sabri A, El Azbaoui S, Alaoui-Tahiri K, Abderrahmani Rhorfi I, Gharbaoui Y, Abid A, Benkirane M, Raharimanga V, Richard V, Orlova M, Boland A, Migaud M, Okada S, Nolan DK, Bustamante J, Barreiro LB, Schurr E, Boisson-Dupuis S, Rasolofo V, Casanova JL, Abel L. Grant AV, et al. Am J Hum Genet. 2013 Mar 7;92(3):407-14. doi: 10.1016/j.ajhg.2013.01.013. Epub 2013 Feb 14. Am J Hum Genet. 2013. PMID: 23415668 Free PMC article.
• Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
  Nabhani S, Ginzel S, Miskin H, Revel-Vilk S, Harlev D, Fleckenstein B, Hönscheid A, Oommen PT, Kuhlen M, Thiele R, Laws HJ, Borkhardt A, Stepensky P, Fischer U. Nabhani S, et al. Haematologica. 2015 Sep;100(9):1189-98. doi: 10.3324/haematol.2014.114967. Epub 2015 Jun 25. Haematologica. 2015. PMID: 26113417 Free PMC article. Clinical Trial.
• Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor.
  Robert M, Miossec P. Robert M, et al. Cell Mol Immunol. 2021 Jul;18(7):1644-1651. doi: 10.1038/s41423-021-00694-9. Epub 2021 May 21. Cell Mol Immunol. 2021. PMID: 34021269 Free PMC article. Review.
• Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity.
  Dendrou CA, Cortes A, Shipman L, Evans HG, Attfield KE, Jostins L, Barber T, Kaur G, Kuttikkatte SB, Leach OA, Desel C, Faergeman SL, Cheeseman J, Neville MJ, Sawcer S, Compston A, Johnson AR, Everett C, Bell JI, Karpe F, Ultsch M, Eigenbrot C, McVean G, Fugger L. Dendrou CA, et al. Sci Transl Med. 2016 Nov 2;8(363):363ra149. doi: 10.1126/scitranslmed.aag1974. Sci Transl Med. 2016. PMID: 27807284 Free PMC article.
• Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.
  Casares S, Zong CS, Radu DL, Miller A, Bona CA, Brumeanu TD. Casares S, et al. J Exp Med. 1999 Aug 16;190(4):543-53. doi: 10.1084/jem.190.4.543. J Exp Med. 1999. PMID: 10449525 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • Guide to Pharmacology
  • The Weizmann Institute of Science GeneCards and MalaCards databases